XML 26 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation
 9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
We recognized total stock-based compensation expense in our Condensed Consolidated Statements of Operations as follows (in thousands):
Three months ended September 30, Nine months ended September 30,
2021202020212020
Cost of goods sold
$688 $744 $2,131 $2,168 
Research and development
14,138 14,212 41,779 43,826 
General and administrative
9,831 8,711 28,359 25,255 
Impairment of assets and other costs for terminated program— — — 1,025 
Total stock-based compensation$24,657 $23,667 $72,269 $72,274 
The stock-based compensation expense reported in impairment of assets and other costs for terminated program resulted from executive severance.
We issued stock-based awards our common stock as follows (shares in thousands):
Three months ended September 30, Nine months ended September 30,
2021202020212020
Options granted
397 233 674 282 
Weighted-average grant-date fair value of options granted
$9.36 $11.64 $9.72 $11.68 
RSUs granted
727 693 1,614 1,213 
Weighted-average grant-date fair value of RSUs granted
$16.48 $21.56 $17.98 $21.04 
On June 10, 2021, the stockholders of Nektar approved an amendment to the Amended and Restated 2017 Performance Incentive Plan to increase the aggregate number of shares of Common Stock authorized for issuance thereunder by 5,000,000 shares.